Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

What fueled the previous growth in the metered dose inhaler devices market?

The market size of metered dose inhaler devices has seen significant expansion in the past few years. The growth is expected to continue, projecting to increase from $15.46 billion in 2024 to $16.36 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 5.8%. Multiple factors contribute to this growth in the historic period, including higher incidence rates of diabetes, a surge in the demand for metered dose inhaler devices, an increase in the supply of these devices, and a rising presence of Chronic Obstructive Pulmonary Disease (COPD).

What will be the metered dose inhaler devices market size in the future?

The market of metered dose inhaler devices is estimated to experience robust growth in the coming years. By 2029, the market is anticipated to reach $20.29 billion with a compound annual growth rate (CAGR) of 5.5%. The growth during the projected period can be traced back to the heightened prevalence of chronic obstructive pulmonary diseases, an escalation in asthma cases, a surge in the prevalence of infectious diseases, a rise in diabetes cases, and an increase in respiratory diseases’ rate. Key trends during this period can be expected to include technological advancements, the development of innovative therapies, regulatory approvals, the emergence of new inhaler products, and the utilization of digital marketing tools.

Get your metered dose inhaler devices market report here!

https://www.thebusinessresearchcompany.com/report/metered-dose-inhaler-devices-global-market-report

What main drivers are fueling expansion in the metered dose inhaler devices market?

The escalating incidence of chronic obstructive pulmonary diseases is projected to stimulate the expansion of the metered dose inhaler devices market. Chronic obstructive pulmonary disease (COPD) is an evolving lung disease typified by airflow impediment, generally resulting from long-term exposure to irritants like cigarette smoke. This can lead to symptoms such as breathlessness, coughing, and wheezing. The escalating incidence of COPD results from factors such as tobacco consumption, air pollution, aging population, and delayed diagnosis or treatment. Metered dose inhaler (MDI) devices assist in managing COPD by transporting medication straight to the lungs which offers quick relief and enhances airflow. For example, as per the National Institutes of Health, a government agency based in the US, it’s predicted that the number of COPD incidences will rise from 532 million in 2030 to a total of 592 million by 2050. Consequently, the escalating incidence of chronic obstructive pulmonary diseases fuels the expansion of the metered dose inhaler devices market.

What key areas define the segmentation of the global metered dose inhaler devices market?

The metered dose inhaler devices market covered in this report is segmented –

1) By Type: Desktop Metered Dose Inhaler Devices, Portable Metered Dose Inhaler Devices, Other Types

2) By Distribution Channel: Online, Offline

3) By Application: Asthma, Chronic Obstructive Pulmonary Disease, Other Applications

4) By End-User: Hospitals, Clinics, Homecare Settings, Other End Users

Subsegments:

1) By Desktop Metered Dose Inhaler Devices: Standard desktop MDI devices, High-performance desktop MDI devices, Smart desktop MDI devices

2) By Portable Metered Dose Inhaler Devices: Conventional portable MDI devices, Advanced portable MDI devices, Smart portable MDI devices

3) By Other Types: Nebulizer-Based MDI devices, Dry powder inhaler (DPI) combined devices, Soft mist inhaler (SMI) devices, Other specialized MDI devices

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20878&type=smp

Who are the dominant players expanding their reach in the metered dose inhaler devices market?

Major companies operating in the metered dose inhaler devices market are Pfizer Inc., Merck & Co. Inc., AstraZeneca PLC, GlaxoSmithKline plc, 3M Company, Boehringer Ingelheim GmbH, Teva Pharmaceutical Industries Ltd., Berry Global Inc., AptarGroup Inc., Philips Healthcare, Chiesi Farmaceutici S.p.A., Cipla Limited, Gerresheimer AG, Zydus Lifesciences Limited, Mylan N.V., Nemera, Beximco Pharmaceuticals Limited, Cohero Health Inc., Bespak Europe Ltd., Trudell Medical International, Iconovo AB

What emerging trends are influencing the growth of the metered dose inhaler devices market?

Major companies operating in the metered dose inhaler devices market are focused on developing technologically advanced solutions, such as pressurized metered dose inhalers, to enhance drug delivery efficiency and improve patient compliance. Pressurized metered-dose inhalers (pMDIs) are inhalation devices that deliver a precise amount of medication in aerosol form using a pressurized propellant. For instance, in July 2023, Lupin Limited, an India-based pharmaceutical company, launched Luforbec 100/6, a pressurized metered dose inhaler (pMDI) for the treatment of adult asthma and chronic obstructive pulmonary disease (COPD) in Germany. This product combines beclometasone (100 µg) and formoterol (6 µg), providing an effective solution for patients requiring combination therapy. Notably, Luforbec is priced approximately 47% lower than the fixed reference price, enhancing its accessibility. With asthma affecting about 5% of adults in Germany, this launch underscores Lupin’s commitment to addressing critical healthcare needs and improving patient outcomes in respiratory care.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20878

Which regions are emerging as leaders in the metered dose inhaler devices market?

North America was the largest region in the metered dose inhaler devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the metered dose inhaler devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Respiratory Inhaler Devices Global Market Report 2025

https://thebusinessresearchcompany.com/report/respiratory-inhaler-devices-global-market-report

Dry Powder Inhaler Global Market Report 2025

https://thebusinessresearchcompany.com/report/dry-powder-inhaler-global-market-report

Smart Inhalers Global Global Market Report 2025

https://thebusinessresearchcompany.com/report/smart-inhalers-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: